Neurotransmitter transporters: fruitful targets for CNS drug discovery
about
Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.Aquaporins in the Colon as a New Therapeutic Target in Diarrhea and ConstipationAt what stage of neural processing does cocaine act to boost pursuit of rewards?SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activityAntidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonistTwo discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1)The role of zinc ions in reverse transport mediated by monoamine transporters.Cytoplasmic permeation pathway of neurotransmitter transporters.Journey of a late blooming biochemical neuroscientist.Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.Pharmacogenetics of monoamine transporters.Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant.Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersCandidate genes for antidepressant response to selective serotonin reuptake inhibitorsCompartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brainDrugs of abuse and human placentaFenfluramine disrupts the mitral valve interstitial cell response to serotonin.The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.Identification of novel serotonin transporter compounds by virtual screening.Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.Triple reuptake inhibitors: a patent review (2006 - 2012).Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1.Morphine-Induced Constipation Develops With Increased Aquaporin-3 Expression in the Colon via Increased Serotonin Secretion.Molecular fMRI of Serotonin Transport.A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.Development of serotonin transporter reuptake inhibition assays using JAR cells.Pharmacological characterization of a fluorescent uptake assay for the noradrenaline transporter.Development of norepinephrine transporter reuptake inhibition assays using SK-N-BE(2)C cells.
P2860
Q24298107-0F5B864E-9236-4B85-B0E6-B9682328D642Q24603864-04585678-8837-4C55-AD9D-0C28EEF8AEB4Q26742044-A3FF1AB1-0FE5-466F-8A4F-8F85DA772562Q27313618-D0F83FC5-B12F-424C-B133-40B4276DBB52Q28295413-B221B6DB-161D-468D-8ADF-C8B76731FE7FQ28537732-1E0D5757-F923-4FC6-A47D-A47E9DC733B3Q28582899-93FC3953-3160-45C0-8159-7E94F2FF572AQ34122719-AB97C8B1-E207-4477-8DA0-5208D1D7AB7DQ34202128-07615D98-A3F0-4F74-A26B-85508FA65098Q34648031-E7C6F6BB-8D0F-4D0C-8F65-8358BF3138F5Q35086731-704831AA-804B-46FD-9614-65D100BF640BQ35123142-7BEE6035-1D18-4D7B-B4EE-B8C464BC8EDCQ35207551-3A6E8F26-8891-4CE3-94FD-211DE250D229Q36002440-1AAA01F5-3D56-4C8F-8C02-EC3E3425FEDAQ36394226-197075A2-478E-4384-A108-A1234516C76BQ36432395-E74EC3EF-0EC3-4A3F-94B5-F6566DD8693BQ36718053-6153722B-DF6B-4371-997F-BB5C634A25D1Q36880689-AEF7D109-C12C-4EC3-8A90-34B668DDB0E4Q37009426-06A46D4C-8B98-4269-96BF-9BD8469EA8EEQ37316467-7FB7BD9E-2B40-4AF2-9252-AB7D916E4823Q37627941-1ACF740D-B664-4973-872B-6DEAD74A98C3Q37695877-096A53AE-3127-4F53-921B-ACF0B08E7D82Q37706110-3FB802BF-563F-4A63-A10F-BC78E78A7858Q38167327-FAD29E95-7BBD-4F93-B4F5-35A3CB1F00D9Q40704906-ECACCDAD-E3B5-4DA3-8A55-3D359F4483FBQ42702299-9BFD62F5-10CA-43E6-9132-2FF3EA0E6FE7Q45389491-5A9699EE-EDD3-45A7-BC15-B115D0C9512FQ46653202-ACC84D05-51AF-45CC-A4ED-BCBB6A710C85Q52648128-D32BA972-A690-40DE-AC0E-E1230C53C951Q55043651-312CA16E-6BBC-40DE-BFC2-E640567ECA9DQ55128254-3700EEDA-9E6E-4592-B23E-0BE1E0A18F42
P2860
Neurotransmitter transporters: fruitful targets for CNS drug discovery
description
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Juli 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: July 2000)
@en
vedecký článok (publikovaný 2000-07)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd in 2000-07)
@nl
наукова стаття, опублікована в липні 2000
@uk
مقالة علمية (نشرت في يوليو 2000)
@ar
name
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@ast
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@en
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@nl
type
label
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@ast
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@en
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@nl
prefLabel
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@ast
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@en
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@nl
P2860
P3181
P356
P1433
P1476
Neurotransmitter transporters: fruitful targets for CNS drug discovery
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.MP.4000728
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1037432544